Back to search

Article

Cis-acting Super-Enhancer lncRNAs as Biomarkers of Early-Stage Breast Cancer

2021-08-17

Abstract excerpt

<title>Abstract</title> <p><bold>Background </bold>Increased breast cancer screening over the past four decades has led to a substantial rise in the diagnosis of ductal carcinoma in situ (DCIS). Although DCIS lesions precede invasive ductal carcinoma (IDC), they do not always transform into cancer. The current standard-of-care for DCIS is an aggressive course of therapy to prevent invasive and metastatic disease...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f205a9bb-3754-52d5-86b3-a80114a54acc
DOI
10.21203/rs.3.rs-800791/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cis-acting Super-Enhancer lncRNAs as Biomarkers of Early-Stage Breast CancerDOI 10.21203/rs.3.rs-800791/v1
A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer.Semantic proximity
NSMCE2, a Novel Super-Enhancer-Regulated Gene, is Linked to Poor Prognosis and Therapy Resistance in Breast CancerSemantic proximity
Subtype-specific enhancer RNAs define transcriptional regulators and prognosis in breast cancersSemantic proximity
Integrative analysis reveals genomic and epigenomic signatures of super-enhancers and its constituentsSemantic proximity
An InDel Genomic Variant within a Bifunctional Super-Enhancer for LINC00636 and CD47 Regulation in Breast CancerSemantic proximity
A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancerSemantic proximity
Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations.Semantic proximity
Super-enhancers in the control of cell identity and disease.Semantic proximity
NSMCE2, a Novel Super-Enhancer Regulated Gene, is Linked to Poor Prognosis and Therapy Resistance in Breast CancerSemantic proximity
An InDel Genomic Variant within a Bifunctional Super-Enhancer for LINC00636 and CD47 Regulation in Breast CancerSemantic proximity
Super-enhancer-driven LncRNA LINC02894 mediated by MORC2 promotes colorectal cancer progressionSemantic proximity
A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancerSemantic proximity
Select a neighboring publication to make it the new centre.